| BN/NHsdMcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70.0 days-84.0 days |
8 |
-7.96 |
null |
0.07 |
0.21 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
EC50 value is moles/liter |
|
63121 |
528 |
| BN/NHsdMcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70.0 days-84.0 days |
5 |
0.01 |
umol/l |
0.0 |
0.0 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
|
62800 |
528 |
| BN/NHsdMcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70.0 days-84.0 days |
8 |
0.01 |
umol/l |
0.0 |
0.01 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
|
62798 |
528 |
| BN/NHsdMcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70.0 days-84.0 days |
8 |
1.23 |
E-7mole |
0.27 |
0.76 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
|
63051 |
528 |
| BN/NHsdMcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70.0 days-84.0 days |
20 |
-6.87 |
null |
0.06 |
0.29 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
EC50 value is moles/liter |
Moms and pups used in studies were fed Teklad |
55337 |
522 |
| BN/NHsdMcwi |
concentration of sodium nitroprusside at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70.0 days-84.0 days |
19 |
0.03 |
10E-7mol/l |
0.01 |
0.04 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
Moms and pups used in studies were fed Teklad |
55757 |
522 |
| BN/NHsdMcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70.0 days-84.0 days |
18 |
2.06 |
E-7mole |
0.37 |
1.57 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
Moms and pups used in studies were fed Teklad |
55956 |
522 |
| BN/NHsdMcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70.0 days-84.0 days |
17 |
0.14 |
umol/l |
0.02 |
0.07 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
Moms and pups used in studies were fed Teklad |
54737 |
522 |
| BN/NHsdMcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70.0 days-84.0 days |
24 |
0.19 |
umol/l |
0.05 |
0.24 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
Moms and pups used in studies were fed Teklad |
54967 |
522 |
| BN/NHsdMcwi |
sodium nitroprusside-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70.0 days-84.0 days |
20 |
98.45 |
% |
0.64 |
2.86 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
Moms and pups used in studies were fed Teklad |
56488 |
522 |
| BN/NHsdMcwi |
dose of methacholine at which pulmonary conductance is half its pretreatment value |
controlled air oxygen content (12 %) (for 14 days) then methacholine (0-11.06 mg/kg) and drug dose time series (for 0.2 hours) |
PhysGen Lung data |
pulmonary ventilation trait |
female |
77.0 days-91.0 days |
19 |
2.97 |
mg/kg |
0.71 |
3.09 |
stop flow air displacement plethysmography |
|
|
|
Moms and pups used in studies were fed Teklad |
58985 |
526 |
| BN/NHsdMcwi |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70.0 days-84.0 days |
8 |
66.75 |
% |
4.42 |
12.5 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
|
62651 |
528 |
| BN/NHsdMcwi |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70.0 days-84.0 days |
5 |
53.2 |
% |
4.62 |
10.33 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
|
62653 |
528 |
| BN/NHsdMcwi |
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70.0 days-84.0 days |
5 |
-6.71 |
null |
0.05 |
0.1 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
|
62876 |
528 |
| BN/NHsdMcwi |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70.0 days-84.0 days |
18 |
61.94 |
% |
3.77 |
16.0 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
Moms and pups used in studies were fed Teklad |
57286 |
522 |
| BN/NHsdMcwi |
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70.0 days-84.0 days |
18 |
-6.8 |
null |
0.07 |
0.31 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
Moms and pups used in studies were fed Teklad |
55687 |
522 |
| BN/NHsdMcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70.0 days-84.0 days |
18 |
1.35 |
E-7mole |
0.19 |
0.79 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
Moms and pups used in studies were fed Teklad |
55957 |
522 |
| BN/NHsdMcwi |
logarithm of the concentration of sodium nitroprusside at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70.0 days-84.0 days |
20 |
-8.63 |
null |
0.09 |
0.4 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
Moms and pups used in studies were fed Teklad |
56040 |
522 |
| BN/NHsdMcwi |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70.0 days-84.0 days |
18 |
60.83 |
% |
3.75 |
15.89 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
Moms and pups used in studies were fed Teklad |
54840 |
522 |
| BN/NHsdMcwi |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70.0 days-84.0 days |
20 |
66.8 |
% |
3.88 |
17.34 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
Moms and pups used in studies were fed Teklad |
54841 |
522 |
| BN/NHsdMcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70.0 days-84.0 days |
20 |
0.31 |
umol/l |
0.12 |
0.55 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
Moms and pups used in studies were fed Teklad |
54966 |
522 |
| BN/NHsdMcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70.0 days-84.0 days |
18 |
3.1 |
E-7mole |
0.51 |
2.18 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
Moms and pups used in studies were fed Teklad |
56580 |
522 |
| BN/NHsdMcwi |
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70.0 days-84.0 days |
18 |
-6.67 |
null |
0.11 |
0.48 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
Moms and pups used in studies were fed Teklad |
56975 |
522 |
| BN/NHsdMcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70.0 days-84.0 days |
5 |
2.01 |
E-7mole |
0.22 |
0.48 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
|
63053 |
528 |
| BN/NHsdMcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70.0 days-84.0 days |
17 |
-6.9 |
null |
0.05 |
0.22 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
EC50 value is moles/liter |
Moms and pups used in studies were fed Teklad |
55338 |
522 |
| BN/NHsdMcwi |
logarithm of the concentration of sodium nitroprusside at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70.0 days-84.0 days |
19 |
-8.78 |
null |
0.08 |
0.36 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
Moms and pups used in studies were fed Teklad |
54631 |
522 |
| BN/NHsdMcwi |
logarithm of the concentration of sodium nitroprusside at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70.0 days-84.0 days |
20 |
-8.81 |
null |
0.05 |
0.21 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
Moms and pups used in studies were fed Teklad |
54632 |
522 |
| BN/NHsdMcwi |
concentration of sodium nitroprusside at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70.0 days-84.0 days |
16 |
0.02 |
10E-7mol/l |
0.0 |
0.02 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
Moms and pups used in studies were fed Teklad |
56253 |
522 |
| BN/NHsdMcwi |
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70.0 days-84.0 days |
20 |
-6.87 |
null |
0.08 |
0.37 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
Moms and pups used in studies were fed Teklad |
56976 |
522 |
| BN/NHsdMcwi |
dose of methacholine at which pulmonary conductance is half its pretreatment value |
methacholine (0-11.06 mg/kg) and drug dose time series (for 0.2 hours) |
PhysGen Lung data |
pulmonary ventilation trait |
male |
77.0 days-91.0 days |
16 |
1.44 |
mg/kg |
0.18 |
0.74 |
stop flow air displacement plethysmography |
|
|
|
Moms and pups used in studies were fed Teklad |
59235 |
526 |
| BN/NHsdMcwi |
concentration of sodium nitroprusside at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70.0 days-84.0 days |
20 |
0.02 |
10E-7mol/l |
0.0 |
0.01 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
Moms and pups used in studies were fed Teklad |
55758 |
522 |
| BN/NHsdMcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70.0 days-84.0 days |
20 |
0.17 |
umol/l |
0.03 |
0.14 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
Moms and pups used in studies were fed Teklad |
54736 |
522 |
| BN/NHsdMcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70.0 days-84.0 days |
20 |
-6.8 |
null |
0.1 |
0.44 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
EC50 value is moles/liter |
Moms and pups used in studies were fed Teklad |
56165 |
522 |
| BN/NHsdMcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70.0 days-84.0 days |
24 |
-6.97 |
null |
0.07 |
0.36 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
EC50 value is moles/liter |
Moms and pups used in studies were fed Teklad |
56166 |
522 |
| BN/NHsdMcwi |
concentration of sodium nitroprusside at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70.0 days-84.0 days |
20 |
0.04 |
10E-7mol/l |
0.01 |
0.04 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
Moms and pups used in studies were fed Teklad |
56252 |
522 |
| BN/NHsdMcwi |
sodium nitroprusside-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70.0 days-84.0 days |
20 |
99.2 |
% |
0.44 |
1.99 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
Moms and pups used in studies were fed Teklad |
56327 |
522 |
| BN/NHsdMcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70.0 days-84.0 days |
20 |
1.89 |
E-7mole |
0.46 |
2.07 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
Moms and pups used in studies were fed Teklad |
56581 |
522 |
| BN/NHsdMcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70.0 days-84.0 days |
5 |
-8.13 |
null |
0.03 |
0.07 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
EC50 value is moles/liter |
|
63123 |
528 |
| BN/NHsdMcwi |
dose of methacholine at which pulmonary conductance is half its pretreatment value |
controlled air oxygen content (12 %) (for 14 days) then methacholine (0-11.06 mg/kg) and drug dose time series (for 0.2 hours) |
PhysGen Lung data |
pulmonary ventilation trait |
male |
77.0 days-91.0 days |
18 |
1.44 |
mg/kg |
0.17 |
0.71 |
stop flow air displacement plethysmography |
|
|
|
Moms and pups used in studies were fed Teklad |
58984 |
526 |
| BN/NHsdMcwi |
dose of methacholine at which pulmonary conductance is half its pretreatment value |
methacholine (0-11.06 mg/kg) and drug dose time series (for 0.2 hours) |
PhysGen Lung data |
pulmonary ventilation trait |
female |
77.0 days-91.0 days |
14 |
1.73 |
mg/kg |
0.29 |
1.1 |
stop flow air displacement plethysmography |
|
|
|
Moms and pups used in studies were fed Teklad |
59236 |
526 |
| BN/NHsdMcwi |
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70.0 days-84.0 days |
8 |
-6.98 |
null |
0.1 |
0.28 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
|
62874 |
528 |
| BN/NHsdMcwi |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70.0 days-84.0 days |
18 |
62.67 |
% |
3.92 |
16.65 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
Moms and pups used in studies were fed Teklad |
57287 |
522 |
| BN/NHsdMcwi |
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70.0 days-84.0 days |
18 |
-6.94 |
null |
0.06 |
0.26 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
Moms and pups used in studies were fed Teklad |
55688 |
522 |
| BN/NHsdMcwi |
logarithm of the concentration of sodium nitroprusside at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70.0 days-84.0 days |
16 |
-8.92 |
null |
0.07 |
0.29 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
Moms and pups used in studies were fed Teklad |
56041 |
522 |
| BN/NHsdMcwi |
sodium nitroprusside-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70.0 days-84.0 days |
16 |
99.19 |
% |
0.38 |
1.52 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
Moms and pups used in studies were fed Teklad |
56328 |
522 |
| BN/NHsdMcwi |
sodium nitroprusside-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70.0 days-84.0 days |
19 |
99.37 |
% |
0.31 |
1.34 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
Moms and pups used in studies were fed Teklad |
56487 |
522 |